Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema - a long-term analysis from a Swiss perspective
Open Access
- 25 June 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Dermatology
- Vol. 10 (1), 4-9
- https://doi.org/10.1186/1471-5945-10-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Successful retreatment with alitretinoin in patients with relapsed chronic hand eczemaBritish Journal of Dermatology, 2009
- Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in SwitzerlandCurrent Medical Research and Opinion, 2008
- Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trialBritish Journal of Dermatology, 2008
- Educational and dermatological aspects of secondary individual prevention in healthcare workersContact Dermatitis, 2006
- Overview of studies of treatments for hand eczema-the EDEN hand eczema surveyBritish Journal of Dermatology, 2004
- Skin protection programmesContact Dermatitis, 2002
- The cost of atopic dermatitis in the Netherlands: an international comparisonBritish Journal of Dermatology, 2002
- Prognosis and work absence due to occupational contact dermatitisContact Dermatitis, 2002
- Pharmacoeconomics of drug therapy for atopic dermatitisExpert Opinion on Pharmacotherapy, 2002
- The cost of atopic eczemaBritish Journal of Dermatology, 1996